Literature DB >> 16687550

Bisphosphonate-associated mandibular osteonecrosis.

E Carneiro1, P Vibhute, A Montazem, P M Som.   

Abstract

A 66-year-old man with multiple myeloma treated with zoledronic acid, melphalan, and prednisone after a tooth extraction developed severe osteonecrosis of the mandible that was nonresponsive to antibiotic therapy. A CT scan showed innumerable fragmented sequestra in the mandible and some adjacent soft tissue fullness around the mandible. The association between the use of bisphosphonates and osteonecrosis of the jaw has been described only recently.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16687550      PMCID： PMC7975761     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  10 in total

1.  Osteonecrosis of the jaws associated with cancer chemotherapy.

Authors:  J Wang; N M Goodger; M A Pogrel
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

2.  Bisphosphanates and oral cavity avascular bone necrosis.

Authors:  Cesar A Migliorati
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

Review 3.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

4.  Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients.

Authors:  C Witt; A C Borges; K Klein; H J Neumann
Journal:  J Oral Maxillofac Surg       Date:  1997-05       Impact factor: 1.895

5.  Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.

Authors:  J R Berenson; L S Rosen; A Howell; L Porter; R E Coleman; W Morley; R Dreicer; S A Kuross; A Lipton; J J Seaman
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

Review 6.  Neuralgia-inducing cavitational osteonecrosis (NICO). Osteomyelitis in 224 jawbone samples from patients with facial neuralgia.

Authors:  J E Bouquot; A M Roberts; P Person; J Christian
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-03

7.  American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Authors:  James R Berenson; Bruce E Hillner; Robert A Kyle; Ken Anderson; Allan Lipton; Gary C Yee; J Sybil Biermann
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

8.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

9.  Spontaneous tooth exfoliation and osteonecrosis following a herpes zoster infection of the fifth cranial nerve.

Authors:  R Mostofi; H Marchmont-Robinson; S Freije
Journal:  J Oral Maxillofac Surg       Date:  1987-03       Impact factor: 1.895

10.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895
  10 in total
  2 in total

Review 1.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

2.  Imaging findings of bisphosphonate-associated osteonecrosis of the jaws.

Authors:  P M Phal; R W T Myall; L A Assael; J L Weissman
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.